InsidersTradesSigma
Follow the 开立医疗 share price and the full management transaction log of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 开立医疗 has published 5 public disclosures. Market capitalisation: €8.4bn. The latest transaction was disclosed on 30 September 2022 (Sale). Among the most active insiders: 周文平. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€7m
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 开立医疗 Buy (bullish), based on 4 analysts. Average price target: CN¥31.64.
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,252 of 29,064 companies
46.4
score / 100
Value29
Quality64
FCF yld-2.3%
Earn yld2.4%
EV/EBITDA32.1x
ROE5.6%
Gross mgn62%
Net mgn8.5%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 September 2022
Declarations5 total
5 of 5 declarations
关于 开立医疗
开立医疗是一家专注于医疗健康和制药领域的公司，提供创新的医疗解决方案。该公司在深圳证券交易所上市。